210 related articles for article (PubMed ID: 35851655)
1. Autoimmune parkinsonism with faciobrachiocrural dystonic seizures: a new phenotype of leucine-rich glioma-inactivated 1 (LGI1) autoimmunity.
Sasikumar S; Vincent J; Gopinath S; Nambiar V; Umesh SU; Kannoth S; Antony D; Mathai A; Anandakuttan A
Acta Neurol Belg; 2022 Oct; 122(5):1323-1328. PubMed ID: 35851655
[TBL] [Abstract][Full Text] [Related]
2. Clinical features of 28 cases of anti
Feng J; Li J; Xie Y; Lü Y; Bi F; Zhou J
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2023 Mar; 48(3):386-396. PubMed ID: 37164922
[TBL] [Abstract][Full Text] [Related]
3. Autoimmune cerebellar ataxia associated with anti-leucine-rich glioma-inactivated protein 1 antibodies: Two pediatric cases.
Weihua Z; Haitao R; Jie D; Changhong R; Ji Z; Anna Z; Hongzhi G; Xiaotun R
J Neuroimmunol; 2022 Sep; 370():577918. PubMed ID: 35853356
[TBL] [Abstract][Full Text] [Related]
4. A case of pediatric anti-leucine-rich glioma inactivated 1 encephalitis with faciobrachial dystonic seizure.
Jang S; Kim SY; Kim WJ; Chae JH; Kim KJ; Lim BC
Brain Dev; 2023 Jun; 45(6):348-353. PubMed ID: 36858863
[TBL] [Abstract][Full Text] [Related]
5. Neurological, psychiatric, and sleep investigations after treatment of anti-leucine-rich glioma-inactivated protein 1 (LGI1) encephalitis in Spain: a prospective cohort study.
Muñoz-Lopetegi A; Guasp M; Prades L; Martínez-Hernández E; Rosa-Justícia M; Patricio V; Armangué T; Rami L; Borràs R; Castro-Fornieles J; Compte A; Gaig C; Santamaria J; Dalmau J;
Lancet Neurol; 2024 Mar; 23(3):256-266. PubMed ID: 38365378
[TBL] [Abstract][Full Text] [Related]
6. Clinical analysis of leucine-rich glioma inactivated-1 protein antibody associated with limbic encephalitis onset with seizures.
Li Z; Cui T; Shi W; Wang Q
Medicine (Baltimore); 2016 Jul; 95(28):e4244. PubMed ID: 27428233
[TBL] [Abstract][Full Text] [Related]
7. Clinical Features, Immunotherapy, and Outcomes of Anti-Leucine-Rich Glioma-Inactivated-1 Encephalitis.
Huang X; Fan C; Gao L; Li L; Ye J; Shen H
J Neuropsychiatry Clin Neurosci; 2022; 34(2):141-148. PubMed ID: 34794327
[TBL] [Abstract][Full Text] [Related]
8. Faciobrachial dystonic seizures: the influence of immunotherapy on seizure control and prevention of cognitive impairment in a broadening phenotype.
Irani SR; Stagg CJ; Schott JM; Rosenthal CR; Schneider SA; Pettingill P; Pettingill R; Waters P; Thomas A; Voets NL; Cardoso MJ; Cash DM; Manning EN; Lang B; Smith SJ; Vincent A; Johnson MR
Brain; 2013 Oct; 136(Pt 10):3151-62. PubMed ID: 24014519
[TBL] [Abstract][Full Text] [Related]
9. Bi-Basal Ganglia Involvement with Signal Evolution in a Case of Anti-LGI1 Encephalitis.
Gai Q; Ruan S; Dong X; Cong S
Neurol India; 2022; 70(1):384-386. PubMed ID: 35263922
[TBL] [Abstract][Full Text] [Related]
10. Autoimmune encephalitis related to LGI1 antibodies with negative MRI study: Description of two cases.
Lian X; Zheng K; Chen W; Li D; Xue F; Wang G
Med Clin (Barc); 2024 Jan; 162(1):35-38. PubMed ID: 37517931
[TBL] [Abstract][Full Text] [Related]
11. What Is Different about Teratoma-Associated Anti-LGI1 Encephalitis? A Long-Term Clinical and Neuroimaging Case Series.
Li C; Cai HB; Zhao X; Xi XC; Zhou Q; Luo HY; Tang ZP; Kang HC; Kirsch HE
Eur Neurol; 2022; 85(6):437-445. PubMed ID: 35896086
[TBL] [Abstract][Full Text] [Related]
12. Persistent hiccup as one of the initial symptoms of leucine-rich glioma-inactivated-1 encephalitis: a case report.
Hou L; Wan L; Li H; Wang Z; Guan H; Ren H; Wang P
BMC Neurol; 2022 Jul; 22(1):281. PubMed ID: 35896991
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic Superiority of 18 F-FDG PET Over MRI in Detecting Anti-LGI1 Autoimmune Encephalitis : A Comparative Study With Insights Into Faciobrachial Dystonic Seizures Mechanisms and Recurrence Identification.
Liang M; Niu N; Jia C; Fan S; Liu L; Cui R; Guan H
Clin Nucl Med; 2023 Nov; 48(11):e516-e522. PubMed ID: 37703438
[TBL] [Abstract][Full Text] [Related]
14. Anti-LGI1 Autoimmune Epilepsy.
Burkett BJ; Johnson DR; Hunt CH; Messina SA; Broski SM
Clin Nucl Med; 2023 Nov; 48(11):956-957. PubMed ID: 37703448
[TBL] [Abstract][Full Text] [Related]
15. The importance of early immunotherapy in patients with faciobrachial dystonic seizures.
Thompson J; Bi M; Murchison AG; Makuch M; Bien CG; Chu K; Farooque P; Gelfand JM; Geschwind MD; Hirsch LJ; Somerville E; Lang B; Vincent A; Leite MI; Waters P; Irani SR;
Brain; 2018 Feb; 141(2):348-356. PubMed ID: 29272336
[TBL] [Abstract][Full Text] [Related]
16. CHI3L1 in the CSF is a potential biomarker for anti-leucine-rich glioma inactivated 1 encephalitis.
Li J; Li H; Wang Y; Zhao X; Wang S; Li L
Front Immunol; 2022; 13():1071219. PubMed ID: 36685530
[TBL] [Abstract][Full Text] [Related]
17. Clinical characteristics and short-term prognosis of LGI1 antibody encephalitis: a retrospective case study.
Li W; Wu S; Meng Q; Zhang X; Guo Y; Cong L; Cong S; Zheng D
BMC Neurol; 2018 Jul; 18(1):96. PubMed ID: 29980179
[TBL] [Abstract][Full Text] [Related]
18. Anti-leucine-rich Glioma Inactivated-1 Encephalitis Associated with Essential Thrombocythemia.
Yuan X; Man X; Zhang J; Sun J; Liang J; Ma H; Tao S; Guo D; Liu L
Intern Med; 2020; 59(2):271-275. PubMed ID: 31941873
[TBL] [Abstract][Full Text] [Related]
19. [Clinical analysis of 9 cases with Anti-leucine-rich glioma inactivated 1 protein antibody associated limbic encephalitis].
Zhang YX; Yang HL; Wu YY; Wang CC; Gao XY; Shi YY; Liu HQ; Huang Y; Zhang JW
Zhonghua Yi Xue Za Zhi; 2017 May; 97(17):1295-1298. PubMed ID: 28482428
[No Abstract] [Full Text] [Related]
20. [Leucine-rich glioma inactivated-1 protein antibody associated limbic encephalitis: one case report].
Zheng YM; Sun W; Wang ZX; Zhang W; Yuan Y
Beijing Da Xue Xue Bao Yi Xue Ban; 2014 Aug; 46(4):646-9. PubMed ID: 25131487
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
